Global Ursodeoxycholic Acid Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Ursodeoxycholic Acid Market Research Report 2024
Ursodeoxycholic Acid is also known as ursodiol (USAN). Ursodeoxycholic acid (3α, 7β-2-hydroxy-5β-bile acid, UDCA) was first found in the bile of a black bear. Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis. In this report, the Ursodeoxycholic Acid we mentioned is Ursodeoxycholic Acid. And the CAS number is 128-13-2.
According to Mr Accuracy reports’s new survey, global Ursodeoxycholic Acid market is projected to reach US$ 943.6 million in 2034, increasing from US$ 445 million in 2022, with the CAGR of 11.2% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ursodeoxycholic Acid market research.
Global Ursodeoxycholic Acid key players include ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Dipharma Francis, etc. Global top five manufacturers hold a share about 65%. Asia-Pacific is the largest market, with a share about 50%, followed by Europe, with a share about 30 percent. In terms of product, Synthetic UDCA is the largest segment, with a share about 95%. And in terms of application, the largest application is Pharmacy, followed by Health Products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ursodeoxycholic Acid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhongshan belling
Dipharma Francis
Grindeks
Erregierre
Abil Chempharma
Biotavia Labs
Suzhou Tianlu
Arcelor Chemicals
Segment by Type
Synthetic UDCA
Extraction UDCA
Pharmacy
Health Products
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Ursodeoxycholic Acid report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Ursodeoxycholic Acid market is projected to reach US$ 943.6 million in 2034, increasing from US$ 445 million in 2022, with the CAGR of 11.2% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ursodeoxycholic Acid market research.
Global Ursodeoxycholic Acid key players include ICE, Mitsubishi Tanabe Pharma, Daewoong Chemical, PharmaZell GmbH, Dipharma Francis, etc. Global top five manufacturers hold a share about 65%. Asia-Pacific is the largest market, with a share about 50%, followed by Europe, with a share about 30 percent. In terms of product, Synthetic UDCA is the largest segment, with a share about 95%. And in terms of application, the largest application is Pharmacy, followed by Health Products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Ursodeoxycholic Acid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
ICE
Mitsubishi Tanabe Pharma
Daewoong Chemical
PharmaZell GmbH
Zhongshan belling
Dipharma Francis
Grindeks
Erregierre
Abil Chempharma
Biotavia Labs
Suzhou Tianlu
Arcelor Chemicals
Segment by Type
Synthetic UDCA
Extraction UDCA
Segment by Application
Pharmacy
Health Products
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Ursodeoxycholic Acid report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices